Vir Biotechnology, Inc.
News
Janet Napolitano Sells 12,190 Shares of Vir Biotechnology, Inc. (NASDAQ:VIR) Stock
Ticker Report Vir Biotechnology, Inc. (NASDAQ:VIR - Get Free Report) Director Janet Napolitano sold 12,190 shares of the firm's stock in a transaction dated Monday, September 9th. The shares were sold at an...\n more…
Vir Biotechnology Appoints Jason OByrne as Chief Financial Officer
Business Wire Vir Biotechnology Inc. (Nasdaq: VIR) today announced that Jason OByrne, MBA, is appointed as Executive Vice President and Chief Financial Officer (CFO), effective October 2, 2024. Mr. OByrne will...\n more…
Vir Biotechnology Announces Closing of Exclusive Worldwide License Agreement With Sanofi for Multiple Potential Best-in-Class Clinical-Stage T-Cell Engagers
Business Wire Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that the exclusive worldwide license agreement with Sanofi announced on August 1, 2024, has closed following expiration of the waiting period...\n more…
Is Vir Biotechnology (NASDAQ:VIR) In A Good Position To Deliver On Growth Plans?
Simply Wall St There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...\n more…
Vir Biotechnology, Inc. (NASDAQ:VIR) Receives Consensus Recommendation of "Moderate Buy" from Analysts
Ticker Report Shares of Vir Biotechnology, Inc. (NASDAQ:VIR - Get Free Report) have received an average recommendation of "Moderate Buy" from the six brokerages that are covering the company, MarketBeat Ratings...\n more…